nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—CYP3A4—Fingolimod—multiple sclerosis	0.056	0.113	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0467	0.0938	CbGbCtD
Voriconazole—CYP3A7—Dexamethasone—multiple sclerosis	0.0467	0.0938	CbGbCtD
Voriconazole—CYP2C19—Prednisone—multiple sclerosis	0.0453	0.0909	CbGbCtD
Voriconazole—CYP2B6—Dexamethasone—multiple sclerosis	0.0445	0.0893	CbGbCtD
Voriconazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0361	0.0725	CbGbCtD
Voriconazole—CYP3A5—Dexamethasone—multiple sclerosis	0.035	0.0704	CbGbCtD
Voriconazole—CYP2C19—Dexamethasone—multiple sclerosis	0.0283	0.0567	CbGbCtD
Voriconazole—CYP3A4—Triamcinolone—multiple sclerosis	0.0274	0.055	CbGbCtD
Voriconazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0263	0.0529	CbGbCtD
Voriconazole—CYP2C9—Dexamethasone—multiple sclerosis	0.0235	0.0472	CbGbCtD
Voriconazole—CYP3A4—Betamethasone—multiple sclerosis	0.0235	0.0472	CbGbCtD
Voriconazole—CYP3A4—Prednisolone—multiple sclerosis	0.0232	0.0465	CbGbCtD
Voriconazole—CYP3A4—Prednisone—multiple sclerosis	0.0219	0.0439	CbGbCtD
Voriconazole—CYP3A4—Dexamethasone—multiple sclerosis	0.0137	0.0274	CbGbCtD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.0026	0.0371	CbGpPWpGaD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.0026	0.0371	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00218	0.0312	CbGpPWpGaD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00186	0.0265	CbGpPWpGaD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00186	0.0265	CbGpPWpGaD
Voriconazole—FMO1—Biological oxidations—CYP27B1—multiple sclerosis	0.00138	0.0197	CbGpPWpGaD
Voriconazole—FMO1—Biological oxidations—CYP24A1—multiple sclerosis	0.00138	0.0197	CbGpPWpGaD
Voriconazole—FMO1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00136	0.0194	CbGpPWpGaD
Voriconazole—FMO1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00136	0.0194	CbGpPWpGaD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00108	0.0154	CbGpPWpGaD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00108	0.0154	CbGpPWpGaD
Voriconazole—FMO3—Biological oxidations—CYP24A1—multiple sclerosis	0.000987	0.0141	CbGpPWpGaD
Voriconazole—FMO3—Biological oxidations—CYP27B1—multiple sclerosis	0.000987	0.0141	CbGpPWpGaD
Voriconazole—FMO3—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000973	0.0139	CbGpPWpGaD
Voriconazole—FMO3—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000973	0.0139	CbGpPWpGaD
Voriconazole—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.000935	0.0133	CbGpPWpGaD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000927	0.0132	CbGpPWpGaD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000927	0.0132	CbGpPWpGaD
Voriconazole—CYP3A7—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000915	0.0131	CbGpPWpGaD
Voriconazole—CYP3A7—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000915	0.0131	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000907	0.0129	CbGpPWpGaD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000752	0.0107	CbGpPWpGaD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000752	0.0107	CbGpPWpGaD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000744	0.0106	CbGpPWpGaD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000744	0.0106	CbGpPWpGaD
Voriconazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.000744	0.0106	CbGpPWpGaD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000729	0.0104	CbGpPWpGaD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000729	0.0104	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000687	0.00981	CbGpPWpGaD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000686	0.00978	CbGpPWpGaD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000686	0.00978	CbGpPWpGaD
Voriconazole—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000677	0.00965	CbGpPWpGaD
Voriconazole—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000677	0.00965	CbGpPWpGaD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00067	0.00956	CbGpPWpGaD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00067	0.00956	CbGpPWpGaD
Voriconazole—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000662	0.00944	CbGpPWpGaD
Voriconazole—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000662	0.00944	CbGpPWpGaD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000584	0.00834	CbGpPWpGaD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000556	0.00793	CbGpPWpGaD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000556	0.00793	CbGpPWpGaD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000544	0.00775	CbGpPWpGaD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000544	0.00775	CbGpPWpGaD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000518	0.00739	CbGpPWpGaD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000518	0.00739	CbGpPWpGaD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000512	0.0073	CbGpPWpGaD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000512	0.0073	CbGpPWpGaD
Voriconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000491	0.007	CbGpPWpGaD
Voriconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000491	0.007	CbGpPWpGaD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000473	0.00674	CbGpPWpGaD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000473	0.00674	CbGpPWpGaD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000466	0.00665	CbGpPWpGaD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000466	0.00665	CbGpPWpGaD
Voriconazole—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000435	0.0062	CbGpPWpGaD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00042	0.00599	CbGpPWpGaD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00042	0.00599	CbGpPWpGaD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000418	0.00596	CbGpPWpGaD
Voriconazole—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.000399	0.0057	CbGpPWpGaD
Voriconazole—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000399	0.0057	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000394	0.00562	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000394	0.00562	CbGpPWpGaD
Voriconazole—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000387	0.00552	CbGpPWpGaD
Voriconazole—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000387	0.00552	CbGpPWpGaD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000383	0.00546	CbGpPWpGaD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000383	0.00546	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000356	0.00507	CbGpPWpGaD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000353	0.00504	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00034	0.00484	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—SRM—multiple sclerosis	0.000335	0.00478	CbGpPWpGaD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000312	0.00445	CbGpPWpGaD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000312	0.00445	CbGpPWpGaD
Voriconazole—FMO1—Biological oxidations—POMC—multiple sclerosis	0.00031	0.00443	CbGpPWpGaD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000308	0.00439	CbGpPWpGaD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000308	0.00439	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000295	0.00421	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000295	0.00421	CbGpPWpGaD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000291	0.00415	CbGpPWpGaD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000291	0.00415	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000289	0.00412	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000289	0.00412	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000285	0.00406	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000285	0.00406	CbGpPWpGaD
Voriconazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00028	0.00399	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000273	0.0039	CbGpPWpGaD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000253	0.0036	CbGpPWpGaD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000253	0.0036	CbGpPWpGaD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000244	0.00347	CbGpPWpGaD
Voriconazole—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000243	0.00346	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—SRM—multiple sclerosis	0.000239	0.00342	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—CYP24A1—multiple sclerosis	0.000236	0.00337	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—CYP27B1—multiple sclerosis	0.000236	0.00337	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000223	0.00318	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000223	0.00318	CbGpPWpGaD
Voriconazole—FMO3—Biological oxidations—POMC—multiple sclerosis	0.000222	0.00317	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.00022	0.00314	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00022	0.00314	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00022	0.00314	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—GPC5—multiple sclerosis	0.000216	0.00308	CbGpPWpGaD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000209	0.00298	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000204	0.0029	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000204	0.0029	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000201	0.00286	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000201	0.00286	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—RRM1—multiple sclerosis	0.000179	0.00255	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000178	0.00254	CbGpPWpGaD
Voriconazole—Loss of consciousness—Betamethasone—multiple sclerosis	0.000172	0.000398	CcSEcCtD
Voriconazole—Epistaxis—Methotrexate—multiple sclerosis	0.000172	0.000397	CcSEcCtD
Voriconazole—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000172	0.000397	CcSEcCtD
Voriconazole—Paraesthesia—Prednisolone—multiple sclerosis	0.000172	0.000397	CcSEcCtD
Voriconazole—Tachycardia—Triamcinolone—multiple sclerosis	0.000172	0.000397	CcSEcCtD
Voriconazole—Mental disorder—Prednisone—multiple sclerosis	0.000171	0.000397	CcSEcCtD
Voriconazole—Nausea—Azathioprine—multiple sclerosis	0.000171	0.000396	CcSEcCtD
Voriconazole—Tachycardia—Methylprednisolone—multiple sclerosis	0.000171	0.000396	CcSEcCtD
Voriconazole—Skin disorder—Methylprednisolone—multiple sclerosis	0.00017	0.000394	CcSEcCtD
Voriconazole—Malnutrition—Prednisone—multiple sclerosis	0.00017	0.000394	CcSEcCtD
Voriconazole—Erythema—Prednisone—multiple sclerosis	0.00017	0.000394	CcSEcCtD
Voriconazole—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00017	0.000393	CcSEcCtD
Voriconazole—Agranulocytosis—Methotrexate—multiple sclerosis	0.00017	0.000393	CcSEcCtD
Voriconazole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00017	0.000393	CcSEcCtD
Voriconazole—Convulsion—Betamethasone—multiple sclerosis	0.000169	0.000392	CcSEcCtD
Voriconazole—Convulsion—Dexamethasone—multiple sclerosis	0.000169	0.000392	CcSEcCtD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000169	0.00241	CbGpPWpGaD
Voriconazole—Hypertension—Betamethasone—multiple sclerosis	0.000169	0.000391	CcSEcCtD
Voriconazole—Hypertension—Dexamethasone—multiple sclerosis	0.000169	0.000391	CcSEcCtD
Voriconazole—FMO3—Metabolism—CYP24A1—multiple sclerosis	0.000169	0.00241	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CYP27B1—multiple sclerosis	0.000169	0.00241	CbGpPWpGaD
Voriconazole—Asthenia—Mitoxantrone—multiple sclerosis	0.000167	0.000387	CcSEcCtD
Voriconazole—Myalgia—Dexamethasone—multiple sclerosis	0.000166	0.000385	CcSEcCtD
Voriconazole—Myalgia—Betamethasone—multiple sclerosis	0.000166	0.000385	CcSEcCtD
Voriconazole—Anxiety—Betamethasone—multiple sclerosis	0.000166	0.000384	CcSEcCtD
Voriconazole—Anxiety—Dexamethasone—multiple sclerosis	0.000166	0.000384	CcSEcCtD
Voriconazole—Discomfort—Dexamethasone—multiple sclerosis	0.000164	0.000381	CcSEcCtD
Voriconazole—Discomfort—Betamethasone—multiple sclerosis	0.000164	0.000381	CcSEcCtD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000164	0.00234	CbGpPWpGaD
Voriconazole—Hypotension—Methylprednisolone—multiple sclerosis	0.000164	0.000379	CcSEcCtD
Voriconazole—Pain—Prednisolone—multiple sclerosis	0.000163	0.000378	CcSEcCtD
Voriconazole—Hepatitis—Methotrexate—multiple sclerosis	0.000163	0.000378	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000163	0.00232	CbGpPWpGaD
Voriconazole—Pharyngitis—Methotrexate—multiple sclerosis	0.000162	0.000375	CcSEcCtD
Voriconazole—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000161	0.000374	CcSEcCtD
Voriconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000161	0.00229	CbGpPWpGaD
Voriconazole—Vision blurred—Prednisone—multiple sclerosis	0.00016	0.000371	CcSEcCtD
Voriconazole—Urethral disorder—Methotrexate—multiple sclerosis	0.00016	0.000371	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00016	0.000371	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00016	0.00037	CcSEcCtD
Voriconazole—Oedema—Betamethasone—multiple sclerosis	0.00016	0.000369	CcSEcCtD
Voriconazole—Oedema—Dexamethasone—multiple sclerosis	0.00016	0.000369	CcSEcCtD
Voriconazole—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00016	0.000369	CcSEcCtD
Voriconazole—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00016	0.000369	CcSEcCtD
Voriconazole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000159	0.000369	CcSEcCtD
Voriconazole—Insomnia—Triamcinolone—multiple sclerosis	0.000159	0.000368	CcSEcCtD
Voriconazole—Insomnia—Methylprednisolone—multiple sclerosis	0.000159	0.000367	CcSEcCtD
Voriconazole—Infection—Betamethasone—multiple sclerosis	0.000158	0.000367	CcSEcCtD
Voriconazole—Infection—Dexamethasone—multiple sclerosis	0.000158	0.000367	CcSEcCtD
Voriconazole—Ill-defined disorder—Prednisone—multiple sclerosis	0.000158	0.000366	CcSEcCtD
Voriconazole—Paraesthesia—Triamcinolone—multiple sclerosis	0.000158	0.000365	CcSEcCtD
Voriconazole—Feeling abnormal—Prednisolone—multiple sclerosis	0.000158	0.000365	CcSEcCtD
Voriconazole—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000158	0.000365	CcSEcCtD
Voriconazole—Visual impairment—Methotrexate—multiple sclerosis	0.000157	0.000365	CcSEcCtD
Voriconazole—Anaemia—Prednisone—multiple sclerosis	0.000157	0.000364	CcSEcCtD
Voriconazole—Shock—Dexamethasone—multiple sclerosis	0.000157	0.000363	CcSEcCtD
Voriconazole—Shock—Betamethasone—multiple sclerosis	0.000157	0.000363	CcSEcCtD
Voriconazole—Dyspnoea—Triamcinolone—multiple sclerosis	0.000157	0.000363	CcSEcCtD
Voriconazole—Nervous system disorder—Betamethasone—multiple sclerosis	0.000156	0.000362	CcSEcCtD
Voriconazole—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000156	0.000362	CcSEcCtD
Voriconazole—Agitation—Prednisone—multiple sclerosis	0.000156	0.000362	CcSEcCtD
Voriconazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000156	0.000362	CcSEcCtD
Voriconazole—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000156	0.000362	CcSEcCtD
Voriconazole—Tachycardia—Betamethasone—multiple sclerosis	0.000156	0.00036	CcSEcCtD
Voriconazole—Tachycardia—Dexamethasone—multiple sclerosis	0.000156	0.00036	CcSEcCtD
Voriconazole—Angioedema—Prednisone—multiple sclerosis	0.000156	0.00036	CcSEcCtD
Voriconazole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000155	0.000358	CcSEcCtD
Voriconazole—Erythema multiforme—Methotrexate—multiple sclerosis	0.000155	0.000358	CcSEcCtD
Voriconazole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000154	0.000357	CcSEcCtD
Voriconazole—FMO3—Metabolism—GPC5—multiple sclerosis	0.000154	0.0022	CbGpPWpGaD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000154	0.0022	CbGpPWpGaD
Voriconazole—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000154	0.000357	CcSEcCtD
Voriconazole—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000154	0.000357	CcSEcCtD
Voriconazole—Malaise—Prednisone—multiple sclerosis	0.000154	0.000355	CcSEcCtD
Voriconazole—Vertigo—Prednisone—multiple sclerosis	0.000153	0.000354	CcSEcCtD
Voriconazole—Eye disorder—Methotrexate—multiple sclerosis	0.000153	0.000353	CcSEcCtD
Voriconazole—Syncope—Prednisone—multiple sclerosis	0.000153	0.000353	CcSEcCtD
Voriconazole—Tinnitus—Methotrexate—multiple sclerosis	0.000152	0.000353	CcSEcCtD
Voriconazole—Anorexia—Betamethasone—multiple sclerosis	0.000152	0.000352	CcSEcCtD
Voriconazole—Anorexia—Dexamethasone—multiple sclerosis	0.000152	0.000352	CcSEcCtD
Voriconazole—Urticaria—Prednisolone—multiple sclerosis	0.000152	0.000352	CcSEcCtD
Voriconazole—Cardiac disorder—Methotrexate—multiple sclerosis	0.000152	0.000351	CcSEcCtD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000151	0.00215	CbGpPWpGaD
Voriconazole—Pain—Triamcinolone—multiple sclerosis	0.00015	0.000348	CcSEcCtD
Voriconazole—Loss of consciousness—Prednisone—multiple sclerosis	0.00015	0.000346	CcSEcCtD
Voriconazole—Hypotension—Dexamethasone—multiple sclerosis	0.000149	0.000345	CcSEcCtD
Voriconazole—Hypotension—Betamethasone—multiple sclerosis	0.000149	0.000345	CcSEcCtD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000149	0.00212	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000149	0.00212	CbGpPWpGaD
Voriconazole—Angiopathy—Methotrexate—multiple sclerosis	0.000148	0.000343	CcSEcCtD
Voriconazole—Vomiting—Mitoxantrone—multiple sclerosis	0.000148	0.000343	CcSEcCtD
Voriconazole—Immune system disorder—Methotrexate—multiple sclerosis	0.000148	0.000342	CcSEcCtD
Voriconazole—Convulsion—Prednisone—multiple sclerosis	0.000147	0.000341	CcSEcCtD
Voriconazole—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000147	0.000341	CcSEcCtD
Voriconazole—Hypertension—Prednisone—multiple sclerosis	0.000147	0.00034	CcSEcCtD
Voriconazole—Rash—Mitoxantrone—multiple sclerosis	0.000147	0.00034	CcSEcCtD
Voriconazole—Dermatitis—Mitoxantrone—multiple sclerosis	0.000147	0.00034	CcSEcCtD
Voriconazole—Chills—Methotrexate—multiple sclerosis	0.000147	0.000339	CcSEcCtD
Voriconazole—Headache—Mitoxantrone—multiple sclerosis	0.000146	0.000338	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000146	0.00208	CbGpPWpGaD
Voriconazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000145	0.000336	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000145	0.000336	CcSEcCtD
Voriconazole—Arthralgia—Prednisone—multiple sclerosis	0.000145	0.000335	CcSEcCtD
Voriconazole—Myalgia—Prednisone—multiple sclerosis	0.000145	0.000335	CcSEcCtD
Voriconazole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000145	0.000335	CcSEcCtD
Voriconazole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000145	0.000335	CcSEcCtD
Voriconazole—Anxiety—Prednisone—multiple sclerosis	0.000144	0.000334	CcSEcCtD
Voriconazole—Alopecia—Methotrexate—multiple sclerosis	0.000144	0.000334	CcSEcCtD
Voriconazole—Insomnia—Dexamethasone—multiple sclerosis	0.000144	0.000334	CcSEcCtD
Voriconazole—Insomnia—Betamethasone—multiple sclerosis	0.000144	0.000334	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000144	0.000333	CcSEcCtD
Voriconazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000143	0.000332	CcSEcCtD
Voriconazole—Paraesthesia—Dexamethasone—multiple sclerosis	0.000143	0.000332	CcSEcCtD
Voriconazole—Paraesthesia—Betamethasone—multiple sclerosis	0.000143	0.000332	CcSEcCtD
Voriconazole—Discomfort—Prednisone—multiple sclerosis	0.000143	0.000331	CcSEcCtD
Voriconazole—Mental disorder—Methotrexate—multiple sclerosis	0.000143	0.000331	CcSEcCtD
Voriconazole—Erythema—Methotrexate—multiple sclerosis	0.000142	0.000329	CcSEcCtD
Voriconazole—Malnutrition—Methotrexate—multiple sclerosis	0.000142	0.000329	CcSEcCtD
Voriconazole—Hypersensitivity—Prednisolone—multiple sclerosis	0.000141	0.000326	CcSEcCtD
Voriconazole—Dyspepsia—Betamethasone—multiple sclerosis	0.00014	0.000325	CcSEcCtD
Voriconazole—Dyspepsia—Dexamethasone—multiple sclerosis	0.00014	0.000325	CcSEcCtD
Voriconazole—Urticaria—Triamcinolone—multiple sclerosis	0.00014	0.000323	CcSEcCtD
Voriconazole—Urticaria—Methylprednisolone—multiple sclerosis	0.000139	0.000323	CcSEcCtD
Voriconazole—Dysgeusia—Methotrexate—multiple sclerosis	0.000139	0.000322	CcSEcCtD
Voriconazole—Body temperature increased—Triamcinolone—multiple sclerosis	0.000139	0.000322	CcSEcCtD
Voriconazole—Anaphylactic shock—Prednisone—multiple sclerosis	0.000139	0.000322	CcSEcCtD
Voriconazole—Oedema—Prednisone—multiple sclerosis	0.000139	0.000322	CcSEcCtD
Voriconazole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000139	0.000321	CcSEcCtD
Voriconazole—Decreased appetite—Betamethasone—multiple sclerosis	0.000139	0.000321	CcSEcCtD
Voriconazole—Decreased appetite—Dexamethasone—multiple sclerosis	0.000139	0.000321	CcSEcCtD
Voriconazole—Nausea—Mitoxantrone—multiple sclerosis	0.000138	0.00032	CcSEcCtD
Voriconazole—Infection—Prednisone—multiple sclerosis	0.000138	0.000319	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000138	0.000319	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000138	0.000319	CcSEcCtD
Voriconazole—Back pain—Methotrexate—multiple sclerosis	0.000138	0.000318	CcSEcCtD
Voriconazole—Shock—Prednisone—multiple sclerosis	0.000137	0.000316	CcSEcCtD
Voriconazole—Pain—Dexamethasone—multiple sclerosis	0.000136	0.000316	CcSEcCtD
Voriconazole—Pain—Betamethasone—multiple sclerosis	0.000136	0.000316	CcSEcCtD
Voriconazole—Nervous system disorder—Prednisone—multiple sclerosis	0.000136	0.000315	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000136	0.00194	CbGpPWpGaD
Voriconazole—Tachycardia—Prednisone—multiple sclerosis	0.000136	0.000314	CcSEcCtD
Voriconazole—Skin disorder—Prednisone—multiple sclerosis	0.000135	0.000312	CcSEcCtD
Voriconazole—Hyperhidrosis—Prednisone—multiple sclerosis	0.000134	0.000311	CcSEcCtD
Voriconazole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000134	0.00191	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000134	0.00191	CbGpPWpGaD
Voriconazole—Vision blurred—Methotrexate—multiple sclerosis	0.000134	0.00031	CcSEcCtD
Voriconazole—Anorexia—Prednisone—multiple sclerosis	0.000132	0.000307	CcSEcCtD
Voriconazole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000132	0.00189	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000132	0.00189	CbGpPWpGaD
Voriconazole—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000132	0.000306	CcSEcCtD
Voriconazole—Anaemia—Methotrexate—multiple sclerosis	0.000131	0.000304	CcSEcCtD
Voriconazole—Feeling abnormal—Betamethasone—multiple sclerosis	0.000131	0.000304	CcSEcCtD
Voriconazole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000131	0.000304	CcSEcCtD
Voriconazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00013	0.000302	CcSEcCtD
Voriconazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00013	0.000302	CcSEcCtD
Voriconazole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00013	0.0003	CcSEcCtD
Voriconazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000129	0.000299	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000129	0.00184	CbGpPWpGaD
Voriconazole—Malaise—Methotrexate—multiple sclerosis	0.000128	0.000297	CcSEcCtD
Voriconazole—FMO3—Metabolism—RRM1—multiple sclerosis	0.000128	0.00182	CbGpPWpGaD
Voriconazole—Vertigo—Methotrexate—multiple sclerosis	0.000128	0.000296	CcSEcCtD
Voriconazole—Leukopenia—Methotrexate—multiple sclerosis	0.000127	0.000295	CcSEcCtD
Voriconazole—Urticaria—Betamethasone—multiple sclerosis	0.000127	0.000293	CcSEcCtD
Voriconazole—Urticaria—Dexamethasone—multiple sclerosis	0.000127	0.000293	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000127	0.000293	CcSEcCtD
Voriconazole—Dizziness—Prednisolone—multiple sclerosis	0.000126	0.000293	CcSEcCtD
Voriconazole—Asthenia—Triamcinolone—multiple sclerosis	0.000126	0.000292	CcSEcCtD
Voriconazole—Abdominal pain—Dexamethasone—multiple sclerosis	0.000126	0.000292	CcSEcCtD
Voriconazole—Body temperature increased—Betamethasone—multiple sclerosis	0.000126	0.000292	CcSEcCtD
Voriconazole—Body temperature increased—Dexamethasone—multiple sclerosis	0.000126	0.000292	CcSEcCtD
Voriconazole—Abdominal pain—Betamethasone—multiple sclerosis	0.000126	0.000292	CcSEcCtD
Voriconazole—Asthenia—Methylprednisolone—multiple sclerosis	0.000126	0.000291	CcSEcCtD
Voriconazole—Insomnia—Prednisone—multiple sclerosis	0.000126	0.000291	CcSEcCtD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000125	0.00178	CbGpPWpGaD
Voriconazole—Paraesthesia—Prednisone—multiple sclerosis	0.000125	0.000289	CcSEcCtD
Voriconazole—Pruritus—Triamcinolone—multiple sclerosis	0.000124	0.000288	CcSEcCtD
Voriconazole—Cough—Methotrexate—multiple sclerosis	0.000124	0.000287	CcSEcCtD
Voriconazole—Pruritus—Methylprednisolone—multiple sclerosis	0.000124	0.000287	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000124	0.00177	CbGpPWpGaD
Voriconazole—Convulsion—Methotrexate—multiple sclerosis	0.000123	0.000285	CcSEcCtD
Voriconazole—Dyspepsia—Prednisone—multiple sclerosis	0.000122	0.000283	CcSEcCtD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000122	0.00174	CbGpPWpGaD
Voriconazole—Arthralgia—Methotrexate—multiple sclerosis	0.000121	0.00028	CcSEcCtD
Voriconazole—Myalgia—Methotrexate—multiple sclerosis	0.000121	0.00028	CcSEcCtD
Voriconazole—Chest pain—Methotrexate—multiple sclerosis	0.000121	0.00028	CcSEcCtD
Voriconazole—Decreased appetite—Prednisone—multiple sclerosis	0.000121	0.00028	CcSEcCtD
Voriconazole—Rash—Prednisolone—multiple sclerosis	0.000121	0.000279	CcSEcCtD
Voriconazole—Dermatitis—Prednisolone—multiple sclerosis	0.00012	0.000279	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00012	0.000278	CcSEcCtD
Voriconazole—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00012	0.000278	CcSEcCtD
Voriconazole—Headache—Prednisolone—multiple sclerosis	0.00012	0.000277	CcSEcCtD
Voriconazole—Discomfort—Methotrexate—multiple sclerosis	0.00012	0.000277	CcSEcCtD
Voriconazole—Constipation—Prednisone—multiple sclerosis	0.000119	0.000275	CcSEcCtD
Voriconazole—Confusional state—Methotrexate—multiple sclerosis	0.000117	0.000271	CcSEcCtD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000117	0.00166	CbGpPWpGaD
Voriconazole—Dizziness—Triamcinolone—multiple sclerosis	0.000116	0.000269	CcSEcCtD
Voriconazole—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000116	0.000269	CcSEcCtD
Voriconazole—Dizziness—Methylprednisolone—multiple sclerosis	0.000116	0.000268	CcSEcCtD
Voriconazole—Infection—Methotrexate—multiple sclerosis	0.000115	0.000267	CcSEcCtD
Voriconazole—Feeling abnormal—Prednisone—multiple sclerosis	0.000114	0.000265	CcSEcCtD
Voriconazole—Asthenia—Dexamethasone—multiple sclerosis	0.000114	0.000265	CcSEcCtD
Voriconazole—Asthenia—Betamethasone—multiple sclerosis	0.000114	0.000265	CcSEcCtD
Voriconazole—Nervous system disorder—Methotrexate—multiple sclerosis	0.000114	0.000264	CcSEcCtD
Voriconazole—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000114	0.000263	CcSEcCtD
Voriconazole—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000114	0.000263	CcSEcCtD
Voriconazole—Nausea—Prednisolone—multiple sclerosis	0.000114	0.000263	CcSEcCtD
Voriconazole—Pruritus—Dexamethasone—multiple sclerosis	0.000113	0.000261	CcSEcCtD
Voriconazole—Pruritus—Betamethasone—multiple sclerosis	0.000113	0.000261	CcSEcCtD
Voriconazole—Skin disorder—Methotrexate—multiple sclerosis	0.000113	0.000261	CcSEcCtD
Voriconazole—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000112	0.00026	CcSEcCtD
Voriconazole—Vomiting—Triamcinolone—multiple sclerosis	0.000112	0.000259	CcSEcCtD
Voriconazole—Vomiting—Methylprednisolone—multiple sclerosis	0.000112	0.000258	CcSEcCtD
Voriconazole—Rash—Triamcinolone—multiple sclerosis	0.000111	0.000257	CcSEcCtD
Voriconazole—Dermatitis—Triamcinolone—multiple sclerosis	0.000111	0.000256	CcSEcCtD
Voriconazole—Anorexia—Methotrexate—multiple sclerosis	0.000111	0.000256	CcSEcCtD
Voriconazole—Rash—Methylprednisolone—multiple sclerosis	0.000111	0.000256	CcSEcCtD
Voriconazole—Dermatitis—Methylprednisolone—multiple sclerosis	0.000111	0.000256	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.00011	0.00158	CbGpPWpGaD
Voriconazole—Urticaria—Prednisone—multiple sclerosis	0.00011	0.000255	CcSEcCtD
Voriconazole—Headache—Triamcinolone—multiple sclerosis	0.00011	0.000255	CcSEcCtD
Voriconazole—Headache—Methylprednisolone—multiple sclerosis	0.00011	0.000254	CcSEcCtD
Voriconazole—Body temperature increased—Prednisone—multiple sclerosis	0.00011	0.000254	CcSEcCtD
Voriconazole—Abdominal pain—Prednisone—multiple sclerosis	0.00011	0.000254	CcSEcCtD
Voriconazole—Diarrhoea—Betamethasone—multiple sclerosis	0.000109	0.000253	CcSEcCtD
Voriconazole—Diarrhoea—Dexamethasone—multiple sclerosis	0.000109	0.000253	CcSEcCtD
Voriconazole—Hypotension—Methotrexate—multiple sclerosis	0.000108	0.000251	CcSEcCtD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000106	0.00152	CbGpPWpGaD
Voriconazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000106	0.000245	CcSEcCtD
Voriconazole—Dizziness—Dexamethasone—multiple sclerosis	0.000105	0.000244	CcSEcCtD
Voriconazole—Dizziness—Betamethasone—multiple sclerosis	0.000105	0.000244	CcSEcCtD
Voriconazole—Insomnia—Methotrexate—multiple sclerosis	0.000105	0.000243	CcSEcCtD
Voriconazole—Nausea—Triamcinolone—multiple sclerosis	0.000104	0.000242	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000104	0.00149	CbGpPWpGaD
Voriconazole—Paraesthesia—Methotrexate—multiple sclerosis	0.000104	0.000241	CcSEcCtD
Voriconazole—Nausea—Methylprednisolone—multiple sclerosis	0.000104	0.000241	CcSEcCtD
Voriconazole—Dyspnoea—Methotrexate—multiple sclerosis	0.000104	0.00024	CcSEcCtD
Voriconazole—Somnolence—Methotrexate—multiple sclerosis	0.000103	0.000239	CcSEcCtD
Voriconazole—FMO1—Metabolism—BCHE—multiple sclerosis	0.000103	0.00147	CbGpPWpGaD
Voriconazole—Hypersensitivity—Prednisone—multiple sclerosis	0.000102	0.000237	CcSEcCtD
Voriconazole—Dyspepsia—Methotrexate—multiple sclerosis	0.000102	0.000237	CcSEcCtD
Voriconazole—Vomiting—Betamethasone—multiple sclerosis	0.000101	0.000235	CcSEcCtD
Voriconazole—Vomiting—Dexamethasone—multiple sclerosis	0.000101	0.000235	CcSEcCtD
Voriconazole—Decreased appetite—Methotrexate—multiple sclerosis	0.000101	0.000234	CcSEcCtD
Voriconazole—Rash—Dexamethasone—multiple sclerosis	0.000101	0.000233	CcSEcCtD
Voriconazole—Rash—Betamethasone—multiple sclerosis	0.000101	0.000233	CcSEcCtD
Voriconazole—Dermatitis—Betamethasone—multiple sclerosis	0.0001	0.000233	CcSEcCtD
Voriconazole—Dermatitis—Dexamethasone—multiple sclerosis	0.0001	0.000233	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.0001	0.000232	CcSEcCtD
Voriconazole—Headache—Betamethasone—multiple sclerosis	9.99e-05	0.000231	CcSEcCtD
Voriconazole—Headache—Dexamethasone—multiple sclerosis	9.99e-05	0.000231	CcSEcCtD
Voriconazole—Asthenia—Prednisone—multiple sclerosis	9.97e-05	0.000231	CcSEcCtD
Voriconazole—Pain—Methotrexate—multiple sclerosis	9.93e-05	0.00023	CcSEcCtD
Voriconazole—Pruritus—Prednisone—multiple sclerosis	9.83e-05	0.000227	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—SRM—multiple sclerosis	9.69e-05	0.00138	CbGpPWpGaD
Voriconazole—Feeling abnormal—Methotrexate—multiple sclerosis	9.57e-05	0.000221	CcSEcCtD
Voriconazole—Diarrhoea—Prednisone—multiple sclerosis	9.51e-05	0.00022	CcSEcCtD
Voriconazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.49e-05	0.00022	CcSEcCtD
Voriconazole—Nausea—Betamethasone—multiple sclerosis	9.48e-05	0.000219	CcSEcCtD
Voriconazole—Nausea—Dexamethasone—multiple sclerosis	9.48e-05	0.000219	CcSEcCtD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.45e-05	0.00135	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—SRM—multiple sclerosis	9.4e-05	0.00134	CbGpPWpGaD
Voriconazole—Urticaria—Methotrexate—multiple sclerosis	9.22e-05	0.000213	CcSEcCtD
Voriconazole—Dizziness—Prednisone—multiple sclerosis	9.19e-05	0.000213	CcSEcCtD
Voriconazole—Abdominal pain—Methotrexate—multiple sclerosis	9.18e-05	0.000212	CcSEcCtD
Voriconazole—Body temperature increased—Methotrexate—multiple sclerosis	9.18e-05	0.000212	CcSEcCtD
Voriconazole—CYP3A7—Biological oxidations—POMC—multiple sclerosis	8.98e-05	0.00128	CbGpPWpGaD
Voriconazole—Vomiting—Prednisone—multiple sclerosis	8.83e-05	0.000204	CcSEcCtD
Voriconazole—Rash—Prednisone—multiple sclerosis	8.76e-05	0.000203	CcSEcCtD
Voriconazole—Dermatitis—Prednisone—multiple sclerosis	8.75e-05	0.000203	CcSEcCtD
Voriconazole—PTGS1—Biological oxidations—POMC—multiple sclerosis	8.71e-05	0.00124	CbGpPWpGaD
Voriconazole—Headache—Prednisone—multiple sclerosis	8.7e-05	0.000201	CcSEcCtD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.62e-05	0.00123	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.57e-05	0.00122	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.57e-05	0.00122	CbGpPWpGaD
Voriconazole—Hypersensitivity—Methotrexate—multiple sclerosis	8.55e-05	0.000198	CcSEcCtD
Voriconazole—Asthenia—Methotrexate—multiple sclerosis	8.33e-05	0.000193	CcSEcCtD
Voriconazole—Nausea—Prednisone—multiple sclerosis	8.25e-05	0.000191	CcSEcCtD
Voriconazole—Pruritus—Methotrexate—multiple sclerosis	8.21e-05	0.00019	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	8.02e-05	0.00114	CbGpPWpGaD
Voriconazole—Diarrhoea—Methotrexate—multiple sclerosis	7.94e-05	0.000184	CcSEcCtD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.82e-05	0.00111	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.82e-05	0.00111	CbGpPWpGaD
Voriconazole—Dizziness—Methotrexate—multiple sclerosis	7.68e-05	0.000178	CcSEcCtD
Voriconazole—Vomiting—Methotrexate—multiple sclerosis	7.38e-05	0.000171	CcSEcCtD
Voriconazole—FMO3—Metabolism—BCHE—multiple sclerosis	7.34e-05	0.00105	CbGpPWpGaD
Voriconazole—Rash—Methotrexate—multiple sclerosis	7.32e-05	0.000169	CcSEcCtD
Voriconazole—Dermatitis—Methotrexate—multiple sclerosis	7.31e-05	0.000169	CcSEcCtD
Voriconazole—Headache—Methotrexate—multiple sclerosis	7.27e-05	0.000168	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—SRM—multiple sclerosis	7.17e-05	0.00102	CbGpPWpGaD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.01e-05	0.001	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—SRM—multiple sclerosis	7.01e-05	0.000999	CbGpPWpGaD
Voriconazole—Nausea—Methotrexate—multiple sclerosis	6.9e-05	0.00016	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	6.83e-05	0.000974	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	6.83e-05	0.000974	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.64e-05	0.000948	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CYP27B1—multiple sclerosis	6.62e-05	0.000944	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CYP24A1—multiple sclerosis	6.62e-05	0.000944	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—POMC—multiple sclerosis	6.49e-05	0.000926	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.47e-05	0.000923	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	6.47e-05	0.000923	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GPC5—multiple sclerosis	6.25e-05	0.000891	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—APOE—multiple sclerosis	6.18e-05	0.000882	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GPC5—multiple sclerosis	6.06e-05	0.000864	CbGpPWpGaD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.68e-05	0.000811	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—SRM—multiple sclerosis	5.42e-05	0.000773	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—POMC—multiple sclerosis	5.31e-05	0.000757	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—RRM1—multiple sclerosis	5.18e-05	0.000738	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.05e-05	0.00072	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.05e-05	0.00072	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.02e-05	0.000716	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—RRM1—multiple sclerosis	5.02e-05	0.000716	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—SRM—multiple sclerosis	4.94e-05	0.000705	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.94e-05	0.000704	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.94e-05	0.000704	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—ALB—multiple sclerosis	4.84e-05	0.00069	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.62e-05	0.000659	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.58e-05	0.000653	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.52e-05	0.000644	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—APOE—multiple sclerosis	4.42e-05	0.00063	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.89e-05	0.000555	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.83e-05	0.000546	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.82e-05	0.000544	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.82e-05	0.000544	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—POMC—multiple sclerosis	3.8e-05	0.000541	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.74e-05	0.000534	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.73e-05	0.000532	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.49e-05	0.000498	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.48e-05	0.000496	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.48e-05	0.000496	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—ALB—multiple sclerosis	3.46e-05	0.000494	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.4e-05	0.000485	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.34e-05	0.000477	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—SRM—multiple sclerosis	3.26e-05	0.000465	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.18e-05	0.000454	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.05e-05	0.000435	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.02e-05	0.000431	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.97e-05	0.000424	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.89e-05	0.000413	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—BCHE—multiple sclerosis	2.88e-05	0.000411	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.64e-05	0.000376	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.3e-05	0.000327	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.3e-05	0.000327	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.24e-05	0.00032	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.2e-05	0.000314	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.15e-05	0.000307	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.1e-05	0.000299	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.05e-05	0.000292	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.93e-05	0.000275	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—APOE—multiple sclerosis	1.79e-05	0.000255	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.76e-05	0.000251	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.76e-05	0.000251	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.74e-05	0.000248	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—APOE—multiple sclerosis	1.73e-05	0.000247	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.66e-05	0.000237	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.6e-05	0.000229	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—POMC—multiple sclerosis	1.54e-05	0.000219	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.000216	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—POMC—multiple sclerosis	1.49e-05	0.000212	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—ALB—multiple sclerosis	1.4e-05	0.0002	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—ALB—multiple sclerosis	1.36e-05	0.000194	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—APOE—multiple sclerosis	1.32e-05	0.000189	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—APOE—multiple sclerosis	1.29e-05	0.000184	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—POMC—multiple sclerosis	1.14e-05	0.000162	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—POMC—multiple sclerosis	1.11e-05	0.000158	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—ALB—multiple sclerosis	1.04e-05	0.000148	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—ALB—multiple sclerosis	1.01e-05	0.000144	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—APOE—multiple sclerosis	1e-05	0.000143	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.99e-06	0.000143	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—APOE—multiple sclerosis	9.11e-06	0.00013	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—POMC—multiple sclerosis	8.59e-06	0.000122	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—POMC—multiple sclerosis	7.83e-06	0.000112	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—ALB—multiple sclerosis	7.83e-06	0.000112	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—ALB—multiple sclerosis	7.14e-06	0.000102	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—APOE—multiple sclerosis	6.01e-06	8.57e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—POMC—multiple sclerosis	5.16e-06	7.36e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—ALB—multiple sclerosis	4.71e-06	6.71e-05	CbGpPWpGaD
